19th Jan 2007 10:22
Sinclair Pharma PLC19 January 2007 Sinclair Pharma plc Notification of Major Interests in Shares Sinclair Pharma plc (LSE: SPH) ("Sinclair" or the "Company") was today informedthat AXA S.A. and its Group companies are deemed to have an interest in a totalof 11,254,078 ordinary shares of 1 pence each in the Company, corresponding to12.05% of the Company's issued share capital. - End - Enquiries: Sinclair Pharma plc +44 (0)1483 410 600Dr Michael Flynn, CEOJerry Randall, CFOZoe McDougall, Communications +44 (0) 7973 792 520John Barrington-Carver, Communications +44 (0) 7831 655 630 Capital MS&L +44 (0) 207 307 5330Mary Clark, Halina Kukula Notes to Editors Sinclair Pharma plc Sinclair Pharma plc is an international specialty pharmaceutical company. Ithas a growing sales and marketing operation that is already present in France,Italy, UK, Spain and Portugal, and a complementary marketing partner networkthat spans more than 60 countries. Sinclair has proven expertise in acquiring or developing commercially attractiveand undervalued products, registering these products and bringing them to marketwithin a short time frame. The company focuses on niche therapeutic areas andits current portfolio includes products for dermatological conditions and oralhealth. "Safe Harbor" Statement under the US Private Securities Litigation Reform Act of1995: Some or all of the statements in this document that relate to futureplans, expectations, events, performances and the like are forward-lookingstatements, as defined in the US Private Securities Litigation Reform Act of1995. Actual results of events could differ materially from those described inthe forward- looking statements due to a variety of factors. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma